Assessment of Real-World Patient-Reported Outcomes in Patients Initiating Biologic Agents for the Treatment of Autoimmune Diseases: An Observational Study in Four Patient-Powered Research Networks

BACKGROUND: The most reliable and meaningful approach for inclusion of patient-reported outcomes (PROs) in the evaluation of real-world clinical effectiveness of biologics in the treatment of autoimmune diseases is u ncertain. This study aimed to assess and compare the proportions of patients who ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Beukelman, Timothy, Long, Millie D, Rhee, Rennie L, Kappelman, Michael D, Merkel, Peter A, Nowell, William Benjamin, Clinton, Cassie, Ringold, Sarah, Del Gaizo, Vincent, Price, Brian, Shaw, Dianne G, Venkatachalam, Shilpa, Cuthbertson, David, Xie, Fenglong, Zhang, Xian, Curtis, Jeffrey R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276583/
https://www.ncbi.nlm.nih.gov/pubmed/37333063
http://dx.doi.org/10.2147/PROM.S392174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276583/
https://www.ncbi.nlm.nih.gov/pubmed/37333063
http://dx.doi.org/10.2147/PROM.S392174

Ejemplares similares